3109 nab-Paclitaxel (nab-P) plus carboplatin (C) as first-line treatment in patients with advanced non-small cell lung cancer (NSCLC): Clinical outcomes by treatment cycle
Gridelli, C., Li, L., O'Brien, M., Ong, T.J., Pirker, R., Socinski, M.A., Thomas, M.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31750-6
Date:
September, 2015
File:
PDF, 73 KB
english, 2015